(Press-News.org) Background and objectives
Tumors are complex systems characterized by variations across genetic, transcriptomic, phenotypic, and microenvironmental levels. This study introduced a novel framework for quantifying cancer cell heterogeneity using single-cell RNA sequencing data. The framework comprised several scores aimed at uncovering the complexities of key cancer traits, such as metastasis, tumor progression, and recurrence.
Methods
This study leveraged publicly available single-cell transcriptomic data from three human breast cancer subtypes: estrogen receptor-positive, human epidermal growth factor receptor 2-positive, and triple-negative. We employed a quantitative approach, analyzing copy number alterations (CNAs), entropy, transcriptomic heterogeneity, and diverse protein-protein interaction networks (PPINs) to explore critical concepts in cancer biology.
Results
We found that entropy and PPIN activity related to the cell cycle could distinguish cell clusters with elevated mitotic activity, particularly in aggressive breast cancer subtypes. Additionally, CNA distributions varied across cancer subtypes. We also identified positive correlations between the CNA score, entropy, and the activities of PPINs associated with the cell cycle, as well as those linked to basal and mesenchymal cell lines.
Conclusions
This study addresses a gap in the current understanding of breast cancer heterogeneity by presenting a novel quantitative approach that offers deeper insight into tumor biology, overcoming some limitations of traditional marker-based methods. Using single-cell RNA sequencing data, this work introduces a novel scoring framework that quantifies key cancer traits, such as CNAs, transcriptomic heterogeneity, entropy and activities of PPIN associated with biological processes relevant to cancer biology. The proposed methodology allows exploring these features at the individual cell level, revealing intra- and inter- tumor heterogeneity that may be relevant for tumor evolution and treatment response. We applied this methodology to human scRNA-seq datasets from ER+, HER2+, TN breast cancer subtypes. Our analysis revealed significant differences in several scores across the subtypes. Overall, this approach enables a better understanding of breast cancer heterogeneity, with the potential to identify novel therapeutic targets and strategies.
Full text
https://www.xiahepublishing.com/1555-3884/GE-2024-00071
The study was recently published in the Gene Expression.
Gene Expression (GE) is an open-access journal. It was launched in 1991 by Chicago Medical School Press, and transferred to Cognizant Communication Corporation in 1994. From August 2022, GE is published by Xia & He Publishing Inc.
GE publishes peer-reviewed and high-quality original articles, reviews, editorials, commentaries, and opinions on its primary research topics including cell biology, molecular biology, genes, and genetics, especially on the cellular and molecular mechanisms of human diseases.
GE has been indexed in Medline (1991-2021), Scopus, Biological Abstracts, Biosis Previews, ProQuest, etc.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
An eight-year study highlights Biscayne Bay as a vital nursery and seasonal refuge for great hammerhead sharks, underscoring its importance across life stages and for long-term shark conservation.
A new study from the University of Miami Rosenstiel School of Marine, Atmospheric, and Earth Science finds that juvenile great hammerhead sharks (Sphyrna mokarran), a critically endangered species, rely heavily on the resources of Florida’s Biscayne Bay as a nursery habitat during their earliest and most vulnerable years.
Nestled within the heart of the Miami metropolitan area, Biscayne Bay is a shallow, subtropical estuary known for its clear ...
New York, NY and Aspen, CO [June 16, 2025] — From the biology of aging to the future of artificial intelligence (AI)-driven medicine, Mount Sinai Health System will participate at the 2025 Aspen Ideas: Health (Sunday, June 22-Wednesday, June 25) and Aspen Ideas Festival (June 25-Tuesday, July 1) in Aspen, Colorado. Mount Sinai is proud to be a presenting underwriter of both festivals, where Mount Sinai thought leaders will lead discussions and the Health System will provide complimentary dermatologic screenings for attendees.
“We return to Aspen ...
CHAMPAIGN, Ill. — A new study offers insight into the health and lifestyle indicators — including diet, physical activity and weight — that align most closely with healthy brain function across the lifespan. The study used machine learning to determine which variables best predicted a person’s ability to quickly complete a task without becoming distracted.
Reported in The Journal of Nutrition, the study found that age, blood pressure and body mass index were the strongest predictors of success on a test called the flanker task, which requires participants to focus ...
MINNEAPOLIS / ST. PAUL (06/16/2024) — In a new study, researchers at the University of Minnesota Twin Cities discovered surprising magnetic behavior in one of the thinnest metallic oxide materials ever made. This could pave the way for the next generation of faster and smarter spintronic and quantum computing devices.
The research is published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS), a peer-reviewed, multidisciplinary, high-impact scientific journal.
Using an advanced materials growth technique—hybrid molecular beam epitaxy—the researchers created ultra-thin layers of RuO2, a compound typically known for ...
Organic chemistry features a wide array of reactions for creating complex molecules, among which the Diels–Alder reaction stands out for its versatility and precision. This reaction enables the construction of intricate polycyclic compounds—structures often found in natural products and pharmaceuticals—by joining dienes and dienophiles with high regio- and stereoselectivity.
One particularly valuable diene for this purpose is ortho-quinodimethane (oQDM), known for its ability to form fused-ring systems. However, synthesizing this reactive intermediate ...
WASHINGTON, DC – June 16, 2025 -- Despite the rise of the new anti-obesity drugs known as GLP-1s, rumors surrounding the death of metabolic and bariatric surgery have been greatly exaggerated. While the number of bariatric procedures were down about 3.5% in 2023 and likely dropped further in 2024, surgery now appears to be rebounding as many GLP-1 patients turn to one-time minimally invasive surgical procedures, including sleeve gastrectomy and gastric bypass, for even more robust and durable results.
“GLP-1 ...
A patch containing tens of millions of microscopic nanoneedles could soon replace traditional biopsies, scientists have found.
The patch offers a painless and less invasive alternative for millions of patients worldwide who undergo biopsies each year to detect and monitor diseases like cancer and Alzheimer’s.
Biopsies are among the most common diagnostic procedures worldwide, performed millions of times every year to detect diseases. However, they are invasive, can cause pain and complications, and can deter patients from seeking early ...
Scientists at UCLA and the University of Toronto have developed an advanced computational tool, called moPepGen, that helps identify previously invisible genetic mutations in proteins, unlocking new possibilities in cancer research and beyond.
The tool, described in Nature Biotechnology, will help understand how changes in our DNA affect proteins and ultimately contribute to cancer, neurodegenerative diseases, and other conditions. It provides a new way to create diagnostic tests and to find treatment targets previously invisible to researchers.
Proteogenomics combines the study of genomics and proteomics to provide a comprehensive molecular profile of diseases. ...
A new hereditary condition has been discovered that affects patients’ ability to repair DNA – leaving them both at greater risk of developing blood cancer, and unable to repair some of the damage caused by chemotherapy treatments.
In a paper published in Nature Communications, an international team of researchers led by cancer genetics experts at the University of Birmingham and funded by Cancer Research UK have found a new disease they call DIAL syndrome.
The rare, inherited ...
New results from a clinical trial reveal that a single dose of psilocybin—a naturally occurring psychedelic compound found in mushrooms—can provide sustained reductions in depression and anxiety in individuals with cancer suffering from major depressive disorder. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
People with cancer often struggle with depression. In this phase 2 trial, 28 patients with cancer and major depressive ...